Third Dose of COVID-19 Vaccine Increases Neutralizing Antibodies Against Omicron in Cancer Patients
The proportion of patients with solid tumors who had neutralizing antibodies against the omicron variant rose from 37% after 2 vaccine doses to 90% after 3 doses.